INNOCAN PHARMA Corp
INNPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,270 | $7,255 | $6,365 | $5,008 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $787 | $730 | $1,084 | $686 |
| Inventory | $2,447 | $2,604 | $2,954 | $3,317 |
| Other Curr. Assets | $401 | $301 | $237 | $69 |
| Total Curr. Assets | $11,024 | $10,937 | $10,710 | $9,147 |
| Property Plant & Equip (Net) | $93 | $100 | $107 | $113 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $93 | $100 | $107 | $113 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $11,117 | $11,037 | $10,817 | $9,260 |
| Liabilities | – | – | – | – |
| Payables | $43 | $233 | $178 | $185 |
| Short-Term Debt | $0 | $3 | $7 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,320 | $2,116 | $1,722 | $1,565 |
| Total Curr. Liab. | $2,962 | $2,954 | $2,627 | $2,238 |
| LT Debt | $1,523 | $1,394 | $1,302 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1,523 | $1,394 | $1,302 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $3 | $7 | $10 |
| Total Liabilities | $4,485 | $4,348 | $3,929 | $2,238 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$38,027 | -$36,080 | -$35,490 | -$34,908 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $3,854 | $4,206 | $4,680 | $5,167 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $2,778 | $2,483 | $2,208 | $1,855 |
| Total Liab. & Tot. Equity | $11,117 | $11,037 | $10,817 | $9,260 |
| Net Debt | -$5,747 | -$5,858 | -$5,056 | -$5,008 |